SCHEMBL3878092

SCHEMBL3878092

CC(C)(C)OC(=O)N1Cc2ccc(N3CCS(=O)(=O)CC3)cc2C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 5/20 0.68
HDAC1 Q13547 1/20 0.54
ESR2 Q92731 1/20 0.51
TMEM97 Q5BJF2 3/20 0.50
SIGMAR1 Q99720 3/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50
DRD1 P21728 1/20 0.50
HRH2 P25021 1/20 0.50
HTR1B P28222 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
HTR1E P28566 1/20 0.50
SLC6A4 P31645 1/20 0.50
HRH1 P35367 1/20 0.50
HTR2B P41595 1/20 0.50
HRH3 Q9Y5N1 1/20 0.50
NR1H2 P55055 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383293 0.89 TMEM97 (0.62) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL38652842 0.87 ABHD6 (0.62) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL3873145 0.87 ABHD6 (0.65) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL31070584 0.86 ABHD6 (0.64) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL31070494 0.85 HDAC1 (0.54) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL2809581 0.84 ABHD6 (0.67) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL3876461 0.82 ABHD6 (0.53) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL3880350 0.81 HDAC1 (0.52) ABHD6HDAC1ESR2TMEM97SIGMAR1
SCHEMBL20983790 0.81 ABHD6 (1.00) ABHD6
SCHEMBL5198323 0.80 ABHD6 (0.64) ABHD6TMEM97SIGMAR1HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-8188139-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
EP-1848694-B1 HETEROCYCLIC SUBSTITUTED PHENYL METHANONES AS INHIBITORS OF THE GLYCINE TRANSPORTER 1 HOFFMANN LA ROCHE (CH) 2009-11-25 EP disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES JOLIDON SYNESE 2009-08-13 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-7557114-B2 Heterocyclic-substituted phenyl methanones HOFFMAN-LA ROCHE INC. (US) 2009-07-07 US disclosed
US-20060178381-A1 Heterocyclic-substituted phenyl methanones HOFFMANN-LA ROCHE INC. 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203665-A1 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES CYP2B6, CYP2D6, CYP1A2 ABHD6 2271/4885HDAC1 1995/4885ESR2 1665/4885
US-20060178381-A1 Heterocyclic-substituted phenyl methanones CYP2B6, CYP2D6, CYP1A2 ABHD6 2271/4885HDAC1 1995/4885ESR2 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.